LDL subfractions and atherogenicity : an hypothesis from the University of GlasgowPACKARD, C. J.Current medical research and opinion. 1996, Vol 13, Num 7, pp 379-390, issn 0300-7995Article

Major statin trials : relationship between lipid changes and cardiovascular eventsPACKARD, C. J.European heart journal supplements. 1999, Vol 1, Num T, pp T2-T6, issn 1520-765XConference Paper

Low-density lipoprotein receptor pathway in man: its role in regulating plasma low-density lipoprotein levelsPACKARD, C. J; SHEPHERD, J.Atherosclerosis reviews. 1983, Vol 11, pp 29-63, issn 0362-1650Article

Lipoprotein heterogeneity and apolipoprotein B metabolismPACKARD, C. J; SHEPHERD, J.Arteriosclerosis, thrombosis, and vascular biology. 1997, Vol 17, Num 12, pp 3542-3556, issn 1079-5642Article

Measurement and meaning of apolipoprotein Al and apolipoprotein B plasma levels : Symposium: APOB and APOA-I - New Markers of Cardiovascular RiskMARCOVINA, S; PACKARD, C. J.Journal of internal medicine. 2006, Vol 259, Num 5, pp 437-446, issn 0954-6820, 10 p.Article

Regression of coronary atherosclerosis: is it possible?SHEPHERD, J; PACKARD, C. J.British heart journal. 1988, Vol 59, Num 2, pp 149-150, issn 0007-0769Article

Receptor-independent low-density lipoprotein catabolismSHEPHERD, J; PACKARD, C. J.Methods in enzymology. 1986, Vol 129, pp 566-590, issn 0076-6879Article

Pathophysiology of human lipoprotein receptors: clinical consequences of a cellular defectSHEPHERD, J; PACKARD, C. J.Journal of clinical pathology. 1984, Vol 37, Num 1, pp 87-94, issn 0021-9746Article

Smoking and plasma lipoprotein metabolismFREEMAN, D. J; PACKARD, C. J.Clinical science (1979). 1995, Vol 89, Num 4, pp 333-342, issn 0143-5221Article

Lipoprotein metabolism in the nephrotic syndromeWARWICK, G. L; PACKARD, C. J.Nephrology, dialysis, transplantation (Print). 1993, Vol 8, Num 5, pp 385-396, issn 0931-0509Article

Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDMTASKINEN, M.-R; PACKARD, C. J; SHEPHERD, J et al.Diabetes (New York, NY). 1990, Vol 39, Num 9, pp 1017-1027, issn 0012-1797, 11 p.Article

Is cholesterol the major lipoprotein risk factor in coronary heart disease ? : a Franco-Scottish overviewFRUCHART, J. C; PACKARD, C. J.Current medical research and opinion. 1997, Vol 13, Num 10, pp 603-616, issn 0300-7995Article

A comparison of commercial kits for the measurement of lipoprotein(a)DAGEN, M. M; PACKARD, C. J; SHEPHERD, J et al.Annals of clinical biochemistry. 1991, Vol 28, pp 359-364, issn 0004-5632, 4Article

Affairs of the heart : cholesterol and coronary heart disease riskSHEPHERD, J; GAFFNEY, D; PACKARD, C. J et al.Disease markers. 1991, Vol 9, Num 2, pp 63-71, issn 0278-0240Article

The effect of sotalol on plasma lipoproteins and apolipoproteinsNORTHCOTE, R. J; PACKARD, C. J; BALLANTYNE, D et al.Clinica chimica acta. 1986, Vol 158, Num 2, pp 187-191, issn 0009-8981Article

Overview of fenofibratePACKARD, C. J.European heart journal. 1998, Vol 19, Num FEV, pp A62-A65, issn 0195-668X, SUPAConference Paper

Receptor-independent catabolism of low density lipoprotein: involvement of the reticuloendothelial systemSLATER, H. R; PACKARD, C. J; SHEPHERD, J et al.The Journal of biological chemistry (Print). 1982, Vol 257, Num 1, pp 307-310, issn 0021-9258Article

FibratesGAW, A; PACKARD, C. J; SHEPHERD, J et al.Handbook of experimental pharmacology. 1994, Vol 109, pp 325-348, issn 0171-2004Article

Action of danazol on plasma lipids and lipoprotein metabolismPACKARD, C. J; SHEPHERD, J.Acta obstetricia et gynecologica Scandinavica. Supplement. 1994, Vol 73, Num 159, pp 35-40, issn 0300-8835Conference Paper

Lipoprotein metabolism in lipase deficient states : studies in primary and secondary hyperlipidaemiaPACKARD, C. J; SHEPHERD, J.Biochemical Society transactions. 1993, Vol 21, Num 2, pp 503-506, issn 0300-5127Conference Paper

Haemochromatosis gene mutations and risk of coronary heart disease: a west of Scotland coronary prevention study (WOSCOPS) substudyGUNN, I. R; MAXWELL, F. K; GAFFNEY, D et al.Heart (London 1996). 2004, Vol 90, Num 3, pp 304-306, issn 1355-6037, 3 p.Article

Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart diseaseSINGH, R. K; MCMAHON, A. D; PATEL, H et al.Heart (London 1996). 2002, Vol 88, Num 1, pp 43-46, issn 1355-6037Article

Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjectsMALMSTRÖM, R; PACKARD, C. J; CASLAKE, M et al.Atherosclerosis. 1999, Vol 146, Num 2, pp 381-390, issn 0021-9150Article

Lipoprotein subfraction concentrations in preeclampsia : Pathogenic parallels to atherosclerosisSATTAR, N; BENDOMIR, A; BERRY, C et al.Obstetrics and gynecology (New York. 1953). 1997, Vol 89, Num 3, pp 403-408, issn 0029-7844Article

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemiaSHEPHERD, J; COBBE, S. M; FORD, I et al.The New England journal of medicine. 1995, Vol 333, Num 20, pp 1301-1307, issn 0028-4793Article